36.7K
Downloads
102
Episodes
Catch up on ’All Things Urticaria’ in this podcast series developed by Global Allergy and Asthma Excellence Network UCARE in collaboration with Medthority. Professor Marcus Maurer, Professor of Dermatology and Allergy at Charité – Universitätsmedizin Berlin, is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Medthority received educational funding from the sponsor to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated content. The opinions in this podcast are of the invited faculty, for informational purposes only, and should not be taken as medical advice. Please consult your regional guidelines for clinical practice recommendations in your area. For updates on ’All Things Urticaria’, sign up on Medthority. For more on UCARE/ACARE activities, visit the UCARE and ACARE websites, UCARE 4U, UDAY, CRUSE Control App, and CURE Registry. Episodes 1 – 61: This content has been developed independently of the sponsor, Novartis Pharma AG. Episode 31 and 33: This content has been in collaboration with J. Uriach y Compañía S.A.
Episodes
Tuesday May 28, 2024
Tuesday May 28, 2024
Professor Elias Toubi joins Professor Marcus Maurer to discuss remission in urticaria, including its definition and possible risk factors for long disease duration.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Additional resources for this episode: Clinical and laboratory parameters in predicting chronic urticaria duration: A prospective study of 139 patients.
Access additional resources by signing up to Medthority and to be notified for future ‘All Things Urticaria’ podcast episodes!
For more information about the UCARE/ACARE network and its activities, please visit: UCARE Website, UCARE LevelUp Program, ACARE Website, UCARE 4U Website, UDAY Website, CRUSE Control App and CURE Registry.